Ranibizumab for neovascular age-related macular degeneration

N Engl J Med. 2007 Feb 15;356(7):748-9; author reply 749-50.
No abstract available

Publication types

  • Comment
  • Letter

MeSH terms

  • Angiogenesis Inhibitors / adverse effects*
  • Angiogenesis Inhibitors / therapeutic use
  • Antibodies, Monoclonal / adverse effects*
  • Antibodies, Monoclonal / therapeutic use
  • Antibodies, Monoclonal, Humanized
  • Female
  • Hemorrhage / chemically induced*
  • Humans
  • Macular Degeneration / drug therapy*
  • Male
  • Ranibizumab
  • Vascular Endothelial Growth Factor A / antagonists & inhibitors*

Substances

  • Angiogenesis Inhibitors
  • Antibodies, Monoclonal
  • Antibodies, Monoclonal, Humanized
  • Vascular Endothelial Growth Factor A
  • Ranibizumab